. 2016 Dec 20;34(2):378–395. doi: 10.1007/s12325-016-0461-z
© The Author(s) 2016
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Fig. 1.
Anti-vascular endothelial growth factor drugs for ocular diseases